UVA (UVA-1) therapy for the treatment of acute GVHD of the skin
M Schlaak, S Schwind, T Wetzig, J Maschke… - Bone marrow …, 2010 - nature.com
… In conclusion, UVA-1 treatment as primary therapy for acute GVHD of the skin is feasible,
well tolerated and effective in an outpatient setting irrespective of age or type of conditioning. …
well tolerated and effective in an outpatient setting irrespective of age or type of conditioning. …
Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin
T Wetzig, M Sticherling, JC Simon… - Bone marrow …, 2005 - nature.com
… patients treated with UVA1 as primary therapy for acute GVHD of the skin as well as the
outcome of UVA1 treatment in 10 patients with chronic GVHD treated at the University of Leipzig. …
outcome of UVA1 treatment in 10 patients with chronic GVHD treated at the University of Leipzig. …
Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study
A Wiesmann, A Weller, G Lischka… - Bone marrow …, 1999 - nature.com
… showed involvement of the liver and gut by acute GVHD. … Furthermore, there are few reports
of successful treatment of acute GVHD … UVA and PUVA therapy in the treatment of cutaneous …
of successful treatment of acute GVHD … UVA and PUVA therapy in the treatment of cutaneous …
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease
T Furlong, W Leisenring, R Storb, C Anasetti… - Biology of Blood and …, 2002 - tctjournal.org
… to treat steroid-resistant acute GVHD of the skin. The objectives of this study were (1) to assess
… ments administered was 16 (range, 1-78), with a mean cumulative UVA exposure of 41 J/…
… ments administered was 16 (range, 1-78), with a mean cumulative UVA exposure of 41 J/…
UV Treatment of Chronic Skin Graft-versus-Host Disease–Focus on UVA1 and Extracorporeal Photopheresis
HT Greinix, A Tanew - Transplantation Dermatology, 2012 - karger.com
… to further subdivide UVA into UVA 2 (far UVA, 320-340 nm) and UVA 1 (near UVA, 340-400
nm). This suggestion was based on the observation that wavelengths in the UVA 2 region …
nm). This suggestion was based on the observation that wavelengths in the UVA 2 region …
[引用][C] UVA1 therapy for sclerodermic graft-versus-host disease of the skin
H Ständer, M Schiller, T Schwarz - Journal of the American Academy of …, 2002 - jaad.org
… extracorporeal photopheresis, chronic sclerodermic GVHD of the skin is … UVA1 (340-400
nm) therapy for scleroderma,1-3 we treated 6 patients who had sclerodermic GVHD with UVA1 …
nm) therapy for scleroderma,1-3 we treated 6 patients who had sclerodermic GVHD with UVA1 …
Treatment of severe erythrodermic acute graft‐versus‐host disease with photochemotherapy
M Kunz, S Wilhelm, M Freund… - British Journal of …, 2001 - academic.oup.com
… divided into acute and chronic GVHD, both displaying a particular pattern. Acute GVHD may
… 8‐methoxypsoralen (0.6 mg kg −1 body weight) was administered 2 h before UVA exposure…
… 8‐methoxypsoralen (0.6 mg kg −1 body weight) was administered 2 h before UVA exposure…
Photochemotherapy for GvHD
I Sniecinski - The International Journal of Artificial Organs, 2000 - journals.sagepub.com
… Acute GvHD is characterized by cytolytic damage of host … Although incidence and
severity of acute GvHD can be … sandwich of clear, UVA transparent acrylic plates with a 1-mm …
severity of acute GvHD can be … sandwich of clear, UVA transparent acrylic plates with a 1-mm …
… of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers
SE Ulirich - Journal of investigative dermatology, 1991 - Elsevier
… acute graft-versus~host disease across complete major histocompatibility barriers in
lethally X-irradiated mice was significantly suppressed after bone marrow transplantation with …
lethally X-irradiated mice was significantly suppressed after bone marrow transplantation with …
Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life
M Ziemer, JJ Thiele, B Gruhn, P Elsner - Journal of the American Academy …, 2004 - jaad.org
… Despite immunosuppressive therapy (100 mg azathioprine and 10 mg prednisolone daily),
he developed acute GVHD of the gastrointestinal tract and 10 months later chronic GVHD of …
he developed acute GVHD of the gastrointestinal tract and 10 months later chronic GVHD of …